CYBB and cardiac hypertrophy: Cardiomyocyte specific upregulation of NOX2 did not aggravate the effects of Ang400 treatment in terms of body weight, cardiac hypertrophy, or expression of hypertrophic markers in csNOX2 TG mice (Table 1).